The current KROS market cap is 2.13B. The company's latest EPS is USD -4.2518 and P/E is -13.92.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 8k |
Operating Income | -27.98M | -31.96M | -38.87M | -41.34M | -43.28M |
Net Income | -23.51M | -29.72M | -35.8M | -37.51M | -39.44M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10M | 0 | 20.1M | 0 | 151k |
Operating Income | -10.56M | -46.66M | -56.37M | -114.79M | -169.94M |
Net Income | -12.34M | -45.36M | -58.74M | -104.68M | -152.99M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 252.55M | 306.78M | 384.44M | 356.31M | 326.25M |
Total Liabilities | 11.53M | 29.36M | 29.45M | 30.05M | 30.41M |
Total Equity | 241.03M | 277.42M | 354.98M | 326.26M | 295.84M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.96M | 269.44M | 255.25M | 306.78M | 370.03M |
Total Liabilities | 10.46M | 7.72M | 12.08M | 29.36M | 37.81M |
Total Equity | -19.45M | 261.72M | 243.17M | 277.42M | 332.21M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -48.62M | -70.06M | -34.24M | -65.07M | -99.05M |
Investing | -890k | -1.24M | -1.06M | -1.37M | -1.92M |
Financing | 58.89M | 120.31M | 107.68M | 109.42M | 109.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -16M | -36.89M | -62.15M | -70.06M | -124.51M |
Investing | -271k | -294k | -1.02M | -1.24M | -2.46M |
Financing | 14k | 296.04M | 28.55M | 120.31M | 178.96M |
Market Cap | 2.13B |
Price to Earnings Ratio | -13.92 |
Price to Sales Ratio | 14.09k |
Price to Cash Ratio | 6.43 |
Price to Book Ratio | 6.41 |
Dividend Yield | - |
Shares Outstanding | 35.98M |
Average Volume (1 week) | 246.64k |
Average Volume (1 Month) | 272.04k |
52 Week Change | 51.02% |
52 Week High | 73.00 |
52 Week Low | 27.02 |
Spread (Intraday) | 0.11 (0.19%) |
Company Name | Keros Therapeutics Inc |
Address |
850 new burton road dover, delaware 19904 |
Website | https://www.kerostx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.